Table 2. Prevalence and titer of IgG antibodies against pathogens in patients and controls.
| Patients (N=368) positive/negative (% positive) | Controls (N=282) positive/negative (% positive) | Group comparison | Patients IgG level (median and IQR) | Controls IgG level (median and IQR) | Group comparison | |
|---|---|---|---|---|---|---|
| HSV-1 | 133/235 (36.1%) | 120/162 (42.6%) | P=0.097 | 31.0, 19.2 | 33.3, 20.6 | P=0.145 |
| HSV-2 | 11/357 (3.0%) | 11/271 (3.9%) | P=0.524 | 19.4, 4.9 | 30.9, 32.8 | P=0.178 |
| VZV | 352/16 (95.6%) | 279/3 (98.9%) | P<0.05 | 77.2, 142.6 | 83.2, 146.6 | P=0.451 |
| EBV | 264/104 (71.7%) | 208/74 (73.8%) | P=0.567 | 19.8, 6.3 | 19.9, 7.5 | P=0.906 |
| CMV | 102/266 (27.7%) | 114/168 (40.4%) | P<0.001 | 33.7, 16.0 | 34.5, 18.5 | P=0.856 |
| TG | 68/300 (18.5%) | 50/232 (17.7%) | P=0.806 | 227.8, 107.7 | 197.6, 102.9 | P=0.232 |
Abbreviations: IgG, immunoglobulin G; IQR, interquartile range.